CNA Staff, Oct 8, 2025 / 09:00 am

The U.S. Catholic bishops sharply criticized the Trump administration’s recent approval of the generic abortion drug mifepristone, saying that women and children deserve better care.

The Food and Drug Administration (FDA) approved the drug even as the administration is currently investigating the abortion drug for safety concerns.

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. has previously acknowledged concerns over the safety of the drug and said in a hearing last month that the investigation is ongoing. Even so, the FDA’s approval of the generic version will make the drug even more accessible.

“Mothers in need and their preborn children deserve better,” said Bishop Daniel Thomas, who heads the U.S. bishops’ pro-life commi

See Full Page